Trial Profile
A Retrospective Study Assessing Efficacy, Safety And Pharmacokinetics Of New Posaconazole Formulations In Patients With Hematologic Malignancy Receiving Antifungal Prophylaxis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary) ; Posaconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 29 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016.